Immunovant Inc. (IMVT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 664 |
| % of all portfolios: | 0.001% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
1 |
$336,900,200 |
| Sells |
33 |
$3,440,960 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Viking Global Investors |
0.11 |
Reduce 39.36% |
1,407,290 |
34,859,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 15 Jan 2025 |
ROIVANT SCIENCES LTD. |
Director , 10% |
13 Jan 2025 |
16,845,010 |
20.00 |
336,900,200 |
| 04 Oct 2023 |
ROIVANT SCIENCES LTD. |
Director , 10% |
02 Oct 2023 |
1,526,316 |
38.00 |
58,000,008 |
| 07 Oct 2022 |
ROIVANT SCIENCES LTD. |
10% |
06 Oct 2022 |
416,667 |
6.00 |
2,500,002 |
| 04 Oct 2022 |
PANDE ATUL |
Director |
30 Sep 2022 |
15,000 |
5.60 |
84,000 |
| 29 Sep 2022 |
TORTI FRANK |
Director |
29 Sep 2022 |
20,000 |
5.81 |
116,200 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock